Patient leaflet - Glycopyrronium Bromide 1 mg / 5 ml oral solution
1. What Glycopyrronium Bromide oral solution is and what it is used for
This medicine is called Glycopyrronium Bromide and belongs to a group of medicines called anticholinergic or antimuscarinic drugs. It contains the active substance glycopyrronium bromide. Each 5 ml dose of oral solution contains 1 mg of glycopyrronium bromide.
- Glycopyrronium bromide is used to treat excessive production of saliva (sialorrhoea) in children and adolescents aged 3 years and older. Sialorrhoea (drooling or excessive salivation) is a common symptom of many diseases of the muscles or nerves. It is mainly caused by poor control of muscles in the face. Acute sialorrhoea may be associated with inflammation, dental or mouth infections. Glycopyrronium Bromide oral solution acts on the salivary glands to reduce production of saliva.
2. What you need to know before you give Glycopyrronium Bromide oral solution
Do not give Glycopyrronium Bromide oral solution if the child:
is allergic (hypersensitive) to
glycopyrronium bromide or any of the other ingredients of this medicine (listed in section 6)
- has glaucoma (increased pressure in the eye)
has a condition called myasthenia gravis
which leads to muscle weakness and fatigue
has an obstruction of the stomach
(pyloric stenosis) or bowel causing vomiting, abdominal pain and swelling (paralytic ileus)
has an enlarged prostate gland (prostatic
hypertrophy)
is unable to completely empty the bladder
(urinary retention)
suffers from chronic end stage kidney
disease and require dialysis
is taking potassium chloride solid dose
products
- is taking anticholinergic medicines Warnings and precautions
Talk to a doctor or pharmacist before giving Glycopyrronium Bromide if the child:
has gastric reflux (a condition in which the
liquid stomach contents backs up into the gullet)
has ulcerative colitis (a chronic
inflammation of the large intestine (colon) which can cause abdominal pain, diarrhoea and bleeding from the back passage) ■ pre-existing constipation
has just had a heart attack or are suffering
from heart disease, irregular heartbeats or high blood pressure, because this medicine can cause a change to their normal heart rate
has a condition characterised by a faster
heartbeat than normal (this can be caused by conditions such as an overactive thyroid gland, heart failure or heart surgery)
is due to have surgery (including at the
dentist) during which they will be ‘put to sleep’ using inhalation anaesthesia. This is because this medicine may cause a change in their normal heart rhythm
has diarrhoea, especially if they have had
an ileostomy or colostomy
has a high temperature (fever) or the
environmental temperature is high (e.g. hot weather outside and high room temperature inside), as this medicine will reduce the amount they sweat, making it harder for their body to cool down. The doctor may need to temporarily reduce the dose given.
has kidney disease, because this
medicine’s dose may need to be decreased
has compromised blood brain barrier
(e.g. brain shunt/tumour and swollen brain can compromise blood brain barrier)
has been told by their doctor that they
have an intolerance to some sugars, because this medicine contains sorbitol In addition, stop treatment and talk to their doctor if the child is suffering with the following:
seem unwell with a very fast or very slow
heart rate
- constipation
- pneumonia
- changes in behaviour
The doctor will decide if treatment should continue and if there should be a dose reduction, after evaluating any of these events. If you are not sure any of the above applies to your child, talk to a doctor or pharmacist before giving Glycopyrronium Bromide oral solution. Glycopyrronium Bromide oral solution reduces salivation which can increase the risk of dental disease, therefore teeth should be brushed daily and have regular dental checks.
Children under 3 years
This medicine is not recommended for children younger than 3 years. Talk to a doctor or pharmacist before taking this medicine or if this medicine has been prescribed for a child less than 3 years. Other medicines and Glycopyrronium Bromide oral solution
Tell the doctor or pharmacist if your child is taking, have recently taken, or might take any other medicines. This includes medicines you have bought without a prescription.
If their doctor tells you to give both this
medicine and one or more similar medicines such as oxybutynin, then they may need to take less than the usual dose of this medicine. This is because of an increased risk of other side effects such as dry mouth, retention of urine and constipation when glycopyrronium bromide and similar medicines are taken together.
Please tell the doctor if your child is taking or have recently taken:
Antidepressants such as amitriptyline, clomipramine, lofepramine or imipramine (known as tricyclic antidepressants) or monoamine oxidase inhibitors (MAOIs)
such as phenelzine, moclobemide, rasagiline, selegiline or tranylcypromine
- Phenothiazines such as chlorpromazine, fluphenazine, prochlorperazine or trifluoperazine, used to treat mental problems or nausea, vomiting or vertigo
- Antihistamines such as promethazine, used to treat allergies
Parasympathomimetics such as
carbachol, neostigmine or physostigmine which affect the transmission of nerve impulses to muscles
- Skeletal muscle relaxants (botulinum toxin)
- Opioids used to treat severe pain
- Corticosteroids such as prednisolone, used to treat various conditions including asthma and inflammation
- Inhaled anaesthetics, given before surgery (including at the dentist)
- Clozapine or haloperidol, used to treat schizophrenia
- Nefopam, used to treat acute and chronic pain
- Domperidone or metoclopramide, used to treat nausea and vomiting
Amantadine or levodopa, used to treat
Parkinson’s disease
- Memantine, used to treat Alzheimer’s disease
Slow-dissolving digoxin tablets,
disopyramide or atenolol, used to treat heart problems
- Metformin, used to treat type 2 diabetes
- Glyceryl trinitrate tablets, used to treat angina. These may not dissolve under the tongue as well as usual because this medicine can cause a dry mouth
- Topiramate or zonisamide, used to treat epilepsy and to prevent migraines
- Potassium chloride containing solid dose products (see section 2 “Do not give Glycopyrronium Bromide oral solution if”)
Anticholinergic medicines. (see section 2,
“Do not give Glycopyrronium Bromide oral solution if”)
Long term use efficacy and safety of Glycopyrronium Bromide oral solution has not been studied beyond the recommended 24 weeks of use. Continued use should be discussed with child’s doctor every 3 months to check that Glycopyrronium Bromide oral solution is still right for the child.
Glycopyrronium Bromide oral solution with food and drink
The effect of Glycopyrronium Bromide oral solution may be reduced when taken with high fat foods. For this reason, this medicine should be given at least one hour before or two hours after meals. Speak to the child’s doctor if administration with a meal is required. Pregnancy and breastfeeding
Glycopyrronium is not recommended in pregnancy or breastfeeding. If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.
Driving and using machines
Glycopyrronium Bromide may make the patient feel drowsy or cause their eyesight to become blurred and this could interfere with their ability to drive or operate machinery safely. Do not drive or operate machinery until these effects have fully cleared. If there is any doubt, ask your doctor for advice.
Glycopyrronium Bromide oral solution contains E420 (sorbitol), E217 and E219
This medicine contains 175 mg sorbitol
(E420) per 1 ml. Sorbitol is a source of fructose. If you have been told by the doctor that your child has an intolerance to some sugars or if your child has been diagnosed with hereditary fructose intolerance (HFI), a rare genetic disorder in which a person cannot break down fructose, talk to your doctor before your child takes or receives this medicine. Sorbitol may cause gastrointestinal discomfort and mild laxative effect.
This medicine contains sodium propyl parahydroxybenzoate (E217) and sodium methyl parahydroxybenzoate (E219).
These may cause allergic reactions (possibly delayed) and exceptionally, bronchospasms (a narrowing of the airways).
This medicinal product contains less than
1 mmol sodium (23 mg) per maximum dose, i.e. essentially is ‘sodium free’.
3. How to use Glycopyrronium Bromide oral solution
Always give this medicine exactly as the doctor has told you.
There are other glycopyrronium bromide oral solutions available. This medicine is not interchangeable with other glycopyrronium medicines without dose adjustment. Do not change between medicines unless advised by your doctor. Read carefully how to use this medicinal product and check with your doctor or pharmacist if you are not sure. Use only the oral syringe included in the container of this product.
This medicine is for oral use only.
This medicine should be given at least one hour before or two hours after a meal. Do not give with high fat foods.
Use in children and adolescents aged 3 years and older
The initial dose will be calculated based on the weight of the child. The dose will be decided by the doctor, using the table below as a guide, and will depend on both the effect of Glycopyrronium Bromide oral solution and any side effects the patient is experiencing. Section 4 includes possible side effects related to the use of Glycopyrronium Bromide oral solution. These should be discussed with the child’s doctor, including those for dose increases and decreases, and at any other time should you be concerned. The child should be monitored at regular intervals to check that Glycopyrronium Bromide oral solution is still the right treatment for them.
| Weight | Dose Level 1 | Dose Level 2 | Dose Level 3 | Dose Level 4 | Dose Level 5 |
| (Kg) | (ml) | (ml) | (ml) | (ml) | (ml) |
| 13-17 | 1.5 | 3 | 4.5 | 6 | 7.5 |
| 18-22 | 2 | 4 | 6 | 8 | 10 |
| 23-27 | 2.5 | 5 | 7.5 | 10 | 12.5 |
| 28-32 | 3 | 6 | 9 | 12 | 15 |
| 33-37 | 3.5 | 7 | 10.5 | 14 | 15 |
| 38-42 | 4 | 8 | 12 | 15 | 15 |
| 43-47 | 4.5 | 9 | 13.5 | 15 | 15 |
| ≥48 | 5 | 10 | 15 | 15 | 15 |
Package Leaflet: Information for the Patient
Glycopyrronium Bromide 1 mg/5 ml Oral Solution
Country
UK
Body text
9pt
Dimensions in mm (H x W x D)
585 x 160
N/A
122962167_404528949
Operator
CG
Version No. Date
01 APR 2026
| PROCESS BLACK |
Directions for use
Give the dose prescribed by your doctor to the child three times each day.
1. Open the bottle and
at first use insert the
PIBA (see pictures
A-B). Note: this may
have been done
already by the
pharmacist.
2. Insert the oral
syringe into the PIBA
and draw out the
required volume from
the inverted bottle (see
pictures C-D). Note:
check you have the
correct level. Maximum
dose of the highest
dose level is 15 ml.
- 3. Remove the filled oral syringe
from the bottle in the upright
position (see picture E).
- 4. Discharge the oral syringe
contents into the child’s mouth.
- 5. Replace the cap on the bottle,
the PIBA remains in place.
- 6. Rinse the oral syringe with warm water and allow to dry after each
use.
If your child is given the medicine through a feeding tube, flush the tube with 20 ml of water after you have given the medicine.
This medicine is not recommended for children less than 3 years of age. Talk to your doctor or pharmacist before giving this medicine to a child if this medicine has been prescribed for a child less than 3 years. If you give more Glycopyrronium Bromide oral solution than you should
If you give more of this medicine than they have been prescribed, they are more likely to experience side effects. Consult the doctor or get medical advice immediately. If possible, give any leftover solution, the bottle and this leaflet to the medical staff so they know what you have given.
If you forget to give Glycopyrronium Bromide oral solution
If you forget to give a dose, give it as soon
as possible. Then give the next dose at the correct time, in accordance with the instructions given to you by the doctor. However, if the next dose is due, do not give the dose you have missed; just give the next dose as normal.
Do not give a double dose to make up
for the forgotten one.
If you have any further questions on the use of this medicine, ask the doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them. If any of the following serious side effects occur, stop giving the medicine and seek medical advice immediately:
Severe allergic reaction (swelling of the
tongue, lips, face or throat) - unknown
Constipation (difficulty in passing stools)
- very common
Urinary retention (unable to completely
empty the bladder) – common
Pneumonia (severe chest infection)
- common
Allergic reaction (hives, difficulty breathing
or swallowing, itching) – uncommon
- Fever (pyrexia) – common
Changes in behaviour such as mood
changes, irritability – very common Other side effects:
Very common side effects (may affect more than 1 in 10 people)
- Dry mouth
- Diarrhoea
- Being sick (vomiting)
- Flushing
- Nasal congestion
- Reduced secretions in the chest
- Reduced secretions in the airways Common side effects (may affect up to 1 in 10 people)
Upper respiratory tract infection (chest
infection)
- Urinary tract infection
- Drowsiness (sleepiness)
- Agitation
- Rash
Uncommon side effects (may affect up to 1 in 100 people)
- Allergy
- Headache
- Involuntary eye movement (nystagmus)
- Bad breath (halitosis)
- Rash (Hives)
- Nose bleeds (epistaxis)
Fungal infection (thrush) of the throat
(oesophageal candidiasis)
- Widening of the pupil of the eye (mydriasis)
- Dehydration
- Thirst
- Urgent need to urinate
- Insomnia (difficulty in sleeping)
Abnormal contractions of digestive tract
when food is ingested (gastrointestinal motility disorder)
A disorder of the muscles and nerves in
the intestine which causes an obstruction or blockage (pseudo-obstruction)
- Dizziness
Unknown side effects (frequency cannot be estimated from the available data)
- Nausea
Angle-closure glaucoma (increased
pressure in the eye)
- Photophobia
- Dry eyes
- Angioedema
Decrease in heart rate (transient
bradycardia)
- Sinus infection (sinusitis)
- Skin dryness
- Sweat inhibition
Reporting of side effects
If you notice any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly to the relevant medicines authority (see details below). By reporting side effects you can help provide more information on the safety of this medicine. United Kingdom: Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store
5. How to store Glycopyrronium Bromide oral solution
Keep this medicine out of the sight and
reach of children.
Do not use this medicine after the expiry
date, which is stated on the label after EXP. The expiry date refers to the last day of that month.
This medicine should be stored below
25°C in its original bottle.
- Do not freeze.
Keep the bottle in the original carton in
order to protect from light.
- Once the bottle has been opened, this medicine should be used within 28 days.
- Do not throw away any medicines via wastewater. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
6. Contents of the pack and other information
What Glycopyrronium Bromide oral solution contains
- The active substance is glycopyrronium bromide. Each 5 ml of oral solution contains 1 mg of glycopyrronium bromide.
The other ingredients are:
o Glycerol
o Sorbitol (E420) (see section 2)
o Sodium methyl parahydroxybenzoate
(E219) (see section 2)
o Sodium propyl parahydroxybenzoate
(E217) (see section 2)
o Citric acid monohydrate
o Trisodium citrate dihydrate
o Strawberry flavour:
- Flavouring substance
- Maltodextrin (maize)
- Acacia (E414)
- Triacetin (E1518)
o Purified water
What Glycopyrronium Bromide oral solution looks like and contents of the pack
Glycopyrronium Bromide oral solution is a clear, colourless, strawberry flavoured liquid supplied in a 150 ml amber glass bottle with a child resistant cap. Each pack contains one 150 ml bottle, a 10 ml syringe and a syringe adaptor. Marketing Authorisation Holder
Colonis Pharma Limited
25 Bedford Square
Bloomsbury
London
WC1B 3HH
United Kingdom
Manufacturers
Labialfarma
Laboratório de Produtos Farmacêuticos e Nutracêuticos, S.A.
Felgueira
Sobral Mortágua
3450-336
Portugal
This leaflet was last revised in April 2026.
Country
UK
Body text
9pt
Dimensions in mm (H x W x D)
585 x 160
N/A
122962167_404528949
Operator
CG
Version No. Date
01 APR 2026
| PROCESS BLACK |
